Loading clinical trials...
Loading clinical trials...
This study aims to evaluate prognostic factors for overall survival and explore risk progression-free survival in ENKTL, and establish a prognostic predictive nomogram for ENKTL patients.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Sun Yat-sen University
NCT05978141 · T-cell Lymphoma, NK-Cell Lymphoma, and more
NCT06406556 · Extranodal NK/T-cell Lymphoma
NCT00336063 · Adult Nasal Type Extranodal NK/T-Cell Lymphoma, Recurrent Nasopharyngeal Keratinizing Squamous Cell Carcinoma, and more
NCT01787409 · Aggressive Non-Hodgkin Lymphoma, Anaplastic Large Cell Lymphoma, and more
NCT01384513 · Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, and more
Sun Yat-sen University Cancer Center
Guangzhou, Guangdong
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions